Suchergebnisse - "Talamonti, M"

PubPharm (13)

1

Dupilumab therapy of atopic dermatitis of the elderly : a multicentre, real-life study

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2021

von Patruno, C. | Napolitano, M. | Argenziano, G. | +56

2

A life with atopic dermatitis : the patient's point of view after a new hope with dupilumab

enthalten in: Clinical and experimental dermatology | 2020

von D'Adamio, S. | Massaro, A. | Biocca, S. | +3

3

Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment : a case series and review of the literature

enthalten in: Expert opinion on biological therapy | 2020

von Caldarola, G. | Pirro, F. | Di Stefani, A. | +11

4

Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene : results from a multicentre study of four European psoriasis cohorts

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2020

von van Vugt, L. | van den Reek, J. | Meulewaeter, E. | +9

CommentIn: J Eur Acad Dermatol Venereol. 2020 Jan;34(1):11-12. - PMID 31930644

5

A safety evaluation of guselkumab for the treatment of psoriasis

enthalten in: Expert opinion on drug safety | 2018

von Galluzzo, M. | D'Adamio, S. | Campione, E. | +2

6

Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis

enthalten in: Expert opinion on drug metabolism & toxicology | 2017

von Galluzzo, M. | Talamonti, M. | D'adamio, S. | +1

7

Brodalumab for the treatment of psoriasis

enthalten in: Expert review of clinical immunology | 2016

von Galluzzo, M. | D'adamio, S. | Bianchi, L. | +1

8

Pharmacogenetics of psoriasis : HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

enthalten in: The British journal of dermatology | 2013

von Talamonti, M. | Botti, E. | Galluzzo, M. | +5

CommentIn: Br J Dermatol. 2013 Aug;169(2):240-1. - PMID 23941250

9

Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab : a retrospective study

enthalten in: Clinical & developmental immunology | 2012

von Teoli, M. | Zangrilli, A. | Chimenti, M. | +5

10

Patients with moderate to severe plaque psoriasis : one year after the European Medicines Agency recommendation of efalizumab suspension

enthalten in: Dermatology (Basel, Switzerland) | 2011

von Talamonti, M. | Teoli, M. | Botti, E. | +3